Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Brief Communication

  • Dual-Tracer PET/CT Protocol with [<sup>18</sup>F]-FDG and [<sup>68</sup>Ga]Ga-FAPI-46 for Cancer Imaging: A Proof of Concept
    You have access
    Dual-Tracer PET/CT Protocol with [18F]-FDG and [68Ga]Ga-FAPI-46 for Cancer Imaging: A Proof of Concept
    Katrin S. Roth, Conrad-Amadeus Voltin, Lutz van Heek, Simone Wegen, Klaus Schomäcker, Thomas Fischer, Simone Marnitz, Alexander Drzezga and Carsten Kobe
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1683-1686; DOI: https://doi.org/10.2967/jnumed.122.263835
  • Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with <sup>177</sup>Lu-PSMA Therapy: A Multicenter Retrospective Analysis
    You have access
    Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with 177Lu-PSMA Therapy: A Multicenter Retrospective Analysis
    Masatoshi Hotta, Andrei Gafita, Johannes Czernin and Jeremie Calais
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1484-1488; DOI: https://doi.org/10.2967/jnumed.121.263441
  • Open Access
    Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study
    Joanne E. Mortimer, James R. Bading, Paul H. Frankel, Mary I. Carroll, Yuan Yuan, Jinha M. Park, Lusine Tumyan, Nikita Gidwaney, Erasmus K. Poku, John E. Shively and David M. Colcher
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1145-1148; DOI: https://doi.org/10.2967/jnumed.121.262940
  • Relationship Between <sup>18</sup>F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
    You have access
    Relationship Between 18F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
    Keith A. Josephs, Nirubol Tosakulwong, Stephen D. Weigand, Marina Buciuc, Val J. Lowe, Dennis W. Dickson and Jennifer L. Whitwell
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 931-935; DOI: https://doi.org/10.2967/jnumed.121.262685
  • Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
    You have access
    Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
    Meiqi Wu, Jing Ning, Jingle Li, Zhichao Lai, Ximin Shi, Haiqun Xing, Marcus Hacker, Bao Liu, Li Huo and Xiang Li
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 948-951; DOI: https://doi.org/10.2967/jnumed.121.262863
  • 
    The Influence of Specific Activity on the Biodistribution of <sup>18</sup>F-rhPSMA-7.3: A Retrospective Analysis of Clinical PET Data
    You have access
    The Influence of Specific Activity on the Biodistribution of 18F-rhPSMA-7.3: A Retrospective Analysis of Clinical PET Data
    Thomas Langbein, Alexander Wurzer, Andrei Gafita, Andrew Robertson, Hui Wang, Ayça Arçay, Michael Herz, Hans-Juergen Wester, Wolfgang A. Weber and Matthias Eiber
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 742-745; DOI: https://doi.org/10.2967/jnumed.121.262471
  • Experience with a Perfusion-Only Screening Protocol for Evaluation of Pulmonary Embolism During the COVID-19 Pandemic Surge
    Open Access
    Experience with a Perfusion-Only Screening Protocol for Evaluation of Pulmonary Embolism During the COVID-19 Pandemic Surge
    Arun Kumar, Renée M. Moadel, Linda B. Haramati, Kenny Ye, Leonard M. Freeman and Lionel S. Zuckier
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 598-601; DOI: https://doi.org/10.2967/jnumed.121.262580
  • 
    Hepatic Artery Injection of <sup>131</sup>I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial
    You have access
    Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial
    Hui Chen, Gang Nan, Ding Wei, Ren-You Zhai, Ming Huang, Wu-Wei Yang, Bao-Cai Xing, Xu Zhu, Hai-Feng Xu, Xiao-Dong Wang, Xiao-Yong Zhang, Bao-Rang Zhu, Peng Liu, Guang Cao, Song Gao, Chun-Yi Hao, Ren-Jie Yang, Jian-Hai Guo, Xin Zhang, Kun Gao, Kun Wang, Jian-Feng Wang, Zi-Yu Li, Lin-Zhong Zhu, Rong Ding, Jing Li, Ling Zhao, Yu-Jun Shao, Hai-Chun Liu, Jie-Lai Xia, Ling Wang, Ling-Min Kong, Zhi-Nan Chen and Huijie Bian
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 556-559; DOI: https://doi.org/10.2967/jnumed.121.262136
  • <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Ligand After <sup>223</sup>Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
    Open Access
    177Lu-Prostate-Specific Membrane Antigen Ligand After 223Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
    Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
  • 
    Value of <sup>68</sup>Ga-DOTATOC and Carbidopa-Assisted <sup>18</sup>F-DOPA PET/CT for Insulinoma Localization
    You have access
    Value of 68Ga-DOTATOC and Carbidopa-Assisted 18F-DOPA PET/CT for Insulinoma Localization
    Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 384-388; DOI: https://doi.org/10.2967/jnumed.121.262401

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire